Staphylococcal scalded skin syndrome (SSSS) is a rare blistering skin disease caused by exfoliative toxin (ET)-producing Staphylococcus aureus, which primarily affects neonates, infants and young children. ET-producing S. aureus can also cause localized bullous impetigo in older children. Of the four ET serotypes, ETA and ETB are generally associated with SSSS. This disease is largely caused by ETproducing methicillin-susceptible S. aureus, but ET-producing methicillinresistant S. aureus (MRSA) strains have been isolated from patients with SSSS or bullous impetigo (Ladhani et al., 1999; Hisata et al., 2011) .
MRSA infections have increased in both hospital and community settings, which has become a major concern worldwide. Community-acquired MRSA (CA-MRSA) strains differ from healthcare-associated MRSA strains based on their genotypes and phenotypes. CA-MRSA isolates usually carry the staphylococcal cassette chromosome (SCC) mec type IV or V and exotoxins such as Panton-Valentine leukocidin and ETs (Fey et al., 2003) . The clonal distribution of predominant CA-MRSA strains varies geographically; sequence type (ST) 1 and ST8 are typically found in the USA; ST80, in European countries; ST30 and ST59, in most Asian countries; and ST72, in Korea (McDougal et al., 2003; Chuang & Huang, 2013 (Ma et al., 2007) . MRSA was phenotypically identified by oxacillin susceptibility test according to the Clinical and Laboratory Standards Institute guidelines (CLSI, 2015) and confirmed by PCR amplification of the mecA gene. Multilocus sequence typing (http://saureus.mlst.net/), SCCmec typing (Oliveira & de Lencastre, 2002; IWG-SCC, 2009 ) and PFGE were performed to analyse the molecular epidemiology of isolates. Toxin genes such as eta, etb, sea, seb, sec, sed, see, seg, she, sei, sej, sen, sem, seo, hla, hlb, hld, hlg, tsst and pvl and resistance genes such as ermA and ermC were detected by PCR using previously reported primers (Jarraud et al., 2002) . The antimicrobial susceptibility of the isolates was determined using the VITEK II system based on the guidelines of CLSI (2015).
A total of 23 S. aureus isolates obtained from patients with SSSS during 2013 to 2015 were mecA positive, showing SCCmec type IIb. All isolates were found to be of ST89 but were classified into two pulsotypes and four antibiograms (Table 1 ). All ST89 CA-MRSA isolates, except one (15CST058), were assigned to one pulsotype at a similarity value of 0.85. The ST89-SCCmec IIb CA-MRSA isolates carried the etb gene, but no pvl gene was detected in any of these isolates. Other toxin genes such as sem, seo, hla, hld and hlg were detected in all tested CA-MRSA isolates (Table 1) . These ST89 CA-MRSA isolates were resistant to clindamycin (n=23), erythromycin (n=23), gentamicin (n=11) and mupirocin (n=4). However, no isolates were resistant to ciprofloxacin, fusidic acid, linezolid, quinupristin/ dalfopristin, rifampin, teicoplanin, tetracycline, trimethoprim/ sulfamethoxazole and vancomycin. All ST89 CA-MRSA isolates carried the ermA gene. (Ma et al., 2007) . However, resistance to mupirocin was detected in only four CA-MRSA isolates from 2013 to 2015.
Epidemiological and microbiological data on S. aureus causing SSSS, but not bullous impetigo, were scarce. This study showed that ST89-SCCmec IIb/etb-positive-pvlnegative CA-MRSA was associated with SSSS in the community studied from 2013 to 2015. Moreover, S. aureus isolates from patients with SSSS from the same community between 2003 and 2005 and between 2013 and 2015 showed identical genotypes regarding ST, SCCmec type and presence of toxin genes. Interestingly, all S. aureus isolates from patients with SSSS were MRSA in this study. ET-producing CA-MRSA strains causing bullous impetigo or SSSS have been identified in Japan, Taiwan and Switzerland (Liassine et al., 2004; Chi et al., 2006; Hisata et al., 2011) . In Korea, the et-positive CA-MRSA isolates were found to be ST72 or ST89 (Park et al., 2015) . ST72 MRSA strains were widely distributed in Korea, whereas ST89 MRSA strains were rarely detected (Kim et al., 2016) . However, Park et al. (2015) recently reported that ST72 and ST89 CA-MRSA isolates were most prevalent among paediatric patients with skin infections in Busan, Korea. These ST89 CA-MRSA isolates were SCCmec II variant, etb positive and pvl negative, suggesting that ST89 CA-MRSA is one of the predominant clones in Kyungnam Province and Busan, Korea. These two areas are adjacently located and are in close proximity to Japan. ST89-IIb/etb-positive CA-MRSA strains were frequently detected in Japanese patients with bullous impetigo or SSSS (Shi et al., 2011) . These results suggest that ST89-SCCmec II/etb-positivepvl-negative MRSA strains were specifically identified in Japan and the southern part of Korea. There are geographic differences in the prevalence of ET types. ETA is predominant in North America and Europe (de Azavedo & Arbuthnott, 1981; Piemont et al., 1984) , whereas ETB is common in Japan and Taiwan (Yamasaki et al., 2005; Chi et al., 2006) . Moreover, Yamasaki et al. (2005) showed a possible correlation between the ET serotype and the clinical form of SSSS. ETA was associated with bullous impetigo, whereas ETB was associated with generalized SSSS. However, eta-positive methicillin-susceptible S. aureus isolates were only identified in patients with atopic dermatitis in Korea (Chung et al., 2008) . Whether ST89-SCCmec IIb/etb-positive CA-MRSA is more commonly associated with SSSS than bullous impetigo in Korea needs to be determined.
This study demonstrates the long-term persistence of ST89-SCCmec IIb/etbpositive-pvl-negative CA-MRSA, which causes SSSS, in a Korean community. Because ST89 CA-MRSA strains with the same genotype as those identified in SSSS herein have been detected in healthy elementary school children in the same Korean community (Lee et al., 2006) , effective preventive strategies to slow the transmission of these bacteria in the community are necessary to control SSSS. 
